Indian Journal of Critical Care Medicine

2020

DOI: 10.5005/jp-journals-10071-23681

|View full text |Cite

|

Sign up to set email alerts

|

Caught Off Guard with COVID-19 Bowel Gangrene: A Case Report

¹

,

²

,

³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Results5

Citation Types

Supporting

0

Mentioning

13

Contrasting

0

Unclassified

2

Year Published

2021

2021

2023

2023

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 8 publications

(15 citation statements)

References 8 publications

(12 reference statements)

Supporting

0

Mentioning

13

Contrasting

0

Unclassified

2

Order By: Relevance

“…After reading the full texts, 7 were excluded (summarized in the Supplementary Table ) [13] , [14] , [15] , [16] , [11] , [17] , [18] . Twelve articles were case reports ( Table 1 ) [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] . In addition, an international survey [31] and a prospective multicenter study were included [32] ( Table 2 ).…”

Section: Resultsmentioning

confidence: 99%

“… [30] . In total, 3 studies were conducted in the united States [24] , [25] , [27] , 4 in Europe [23] , [26] , [29] , [30] , 3 in Asia [19] , [20] , [22] , 1 in South America [28] , and 1 in South Africa [21] . Nine studies were published in 2020 [19] , [21] , [22] , [23] , [24] , [25] , [28] , [29] , [30] .…”

Section: Resultsmentioning

confidence: 99%

“…In total, 3 studies were conducted in the united States [24] , [25] , [27] , 4 in Europe [23] , [26] , [29] , [30] , 3 in Asia [19] , [20] , [22] , 1 in South America [28] , and 1 in South Africa [21] . Nine studies were published in 2020 [19] , [21] , [22] , [23] , [24] , [25] , [28] , [29] , [30] . The total number of patients was 10 females [19] , [21] , [23] , [25] , [26] , [27] , [29] , [30] and 9 males [20] , [22] , [24] , [26] , [28] , [30] .…”

Section: Resultsmentioning

confidence: 99%

“…Nine studies were published in 2020 [19] , [21] , [22] , [23] , [24] , [25] , [28] , [29] , [30] . The total number of patients was 10 females [19] , [21] , [23] , [25] , [26] , [27] , [29] , [30] and 9 males [20] , [22] , [24] , [26] , [28] , [30] . Eight case reports included patients without comorbidity ( n = 14 children) [19] , [20] , [22] , [23] , [25] , [26] , [28] , [30] ; comorbidities ( n = 5) included: tubercolus meningitis (n = 1) [21] , sickle cell disease (n = 1) [29] , asthma (n = 1) [24] , and obesity ( n = 2) [26] , [27] .…”

Section: Resultsmentioning

confidence: 99%

“…Diagnosis of COVID-19 infection was based on RT-PCR assay results of nasopharyngeal swab in 10 studies [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [29] , [30] , SAR-CoV-2-IgM antibody in 1 study [27] and post mortem histopathological examination of the heart showing spherical viral particles consistent with the Coronaviridae family in 1 study [28] .…”

Section: Resultsmentioning

confidence: 99%

See 4 more Smart Citations

Thrombotic risk in children with COVID-19 infection: A systematic review of the literature

¹

,

²

,

³

et al. 2021

Thrombosis Research

View full text Add to dashboard Cite

Coagulation and inflammatory parameters are mildly altered in children with SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and procoagulant state has been noted in multisystem inflammatory syndrome in children (MIS-C). It is not clear whether this pediatric condition is related to thrombotic events. With this study we reviewed the literature for thrombotic complications in children with COVID-19 infection and MIS-C. Data sources: We searched the Medline PubMed Advanced Search Builder, Scopus, Web Of Science, and Google Scholar electronic databases (until 1 January 2021) using the medical subject headings (MeSH) terms and text words (their combinations and truncated synonyms): (THROMBOSIS OR THROMBOPHILIA) AND (CHILD OR CHILDREN OR INFANT) AND (COVID-19 OR SARS-CoV-2). Study eligibility criteria: Inclusion criteria were children with COVID-19 or SARS-COV-2 infection. The search was limited to articles published in English. Exclusion criteria were: reviews of published studies, studies published only as abstracts, letters or conference proceedings, discussion papers, animal studies, or editorials. Results: After screening for duplicates, the initial search yielded 86 records: 12 were case reports involving 19 children; comorbidities were absent or mild in 73.7%. The most common site of thrombosis the lung (21%); the most often used drug was heparin (42%). Two studies were an international survey (n = 337 patients) and a large multicenter study (n = 186 patients with MIS-C). The risk of ischemic stroke in SARS-CoV-2 infection (0.82%) and deep venous thrombosis in MIS-C (4.3%) was lower in children than in adults. Conclusions: Thrombodic or thromboembolic events are rare in pediatric patients with COVID-19 infection and MIS-C. Nonetheless, as in adults, a high index of suspicion should be maintained in children with COVID-19 infection or MIS-C, particularly in those with comorbidities predisposing to thrombotic events.

“…After reading the full texts, 7 were excluded (summarized in the Supplementary Table ) [13] , [14] , [15] , [16] , [11] , [17] , [18] . Twelve articles were case reports ( Table 1 ) [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] . In addition, an international survey [31] and a prospective multicenter study were included [32] ( Table 2 ).…”

Section: Resultsmentioning

confidence: 99%

“… [30] . In total, 3 studies were conducted in the united States [24] , [25] , [27] , 4 in Europe [23] , [26] , [29] , [30] , 3 in Asia [19] , [20] , [22] , 1 in South America [28] , and 1 in South Africa [21] . Nine studies were published in 2020 [19] , [21] , [22] , [23] , [24] , [25] , [28] , [29] , [30] .…”

Section: Resultsmentioning

confidence: 99%

“…In total, 3 studies were conducted in the united States [24] , [25] , [27] , 4 in Europe [23] , [26] , [29] , [30] , 3 in Asia [19] , [20] , [22] , 1 in South America [28] , and 1 in South Africa [21] . Nine studies were published in 2020 [19] , [21] , [22] , [23] , [24] , [25] , [28] , [29] , [30] . The total number of patients was 10 females [19] , [21] , [23] , [25] , [26] , [27] , [29] , [30] and 9 males [20] , [22] , [24] , [26] , [28] , [30] .…”

Section: Resultsmentioning

confidence: 99%

“…Nine studies were published in 2020 [19] , [21] , [22] , [23] , [24] , [25] , [28] , [29] , [30] . The total number of patients was 10 females [19] , [21] , [23] , [25] , [26] , [27] , [29] , [30] and 9 males [20] , [22] , [24] , [26] , [28] , [30] . Eight case reports included patients without comorbidity ( n = 14 children) [19] , [20] , [22] , [23] , [25] , [26] , [28] , [30] ; comorbidities ( n = 5) included: tubercolus meningitis (n = 1) [21] , sickle cell disease (n = 1) [29] , asthma (n = 1) [24] , and obesity ( n = 2) [26] , [27] .…”

Section: Resultsmentioning

confidence: 99%

“…Diagnosis of COVID-19 infection was based on RT-PCR assay results of nasopharyngeal swab in 10 studies [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [29] , [30] , SAR-CoV-2-IgM antibody in 1 study [27] and post mortem histopathological examination of the heart showing spherical viral particles consistent with the Coronaviridae family in 1 study [28] .…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Thrombotic risk in children with COVID-19 infection: A systematic review of the literature

¹

,

²

,

³

et al. 2021

Thrombosis Research

View full text Add to dashboard Cite

Coagulation and inflammatory parameters are mildly altered in children with SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and procoagulant state has been noted in multisystem inflammatory syndrome in children (MIS-C). It is not clear whether this pediatric condition is related to thrombotic events. With this study we reviewed the literature for thrombotic complications in children with COVID-19 infection and MIS-C. Data sources: We searched the Medline PubMed Advanced Search Builder, Scopus, Web Of Science, and Google Scholar electronic databases (until 1 January 2021) using the medical subject headings (MeSH) terms and text words (their combinations and truncated synonyms): (THROMBOSIS OR THROMBOPHILIA) AND (CHILD OR CHILDREN OR INFANT) AND (COVID-19 OR SARS-CoV-2). Study eligibility criteria: Inclusion criteria were children with COVID-19 or SARS-COV-2 infection. The search was limited to articles published in English. Exclusion criteria were: reviews of published studies, studies published only as abstracts, letters or conference proceedings, discussion papers, animal studies, or editorials. Results: After screening for duplicates, the initial search yielded 86 records: 12 were case reports involving 19 children; comorbidities were absent or mild in 73.7%. The most common site of thrombosis the lung (21%); the most often used drug was heparin (42%). Two studies were an international survey (n = 337 patients) and a large multicenter study (n = 186 patients with MIS-C). The risk of ischemic stroke in SARS-CoV-2 infection (0.82%) and deep venous thrombosis in MIS-C (4.3%) was lower in children than in adults. Conclusions: Thrombodic or thromboembolic events are rare in pediatric patients with COVID-19 infection and MIS-C. Nonetheless, as in adults, a high index of suspicion should be maintained in children with COVID-19 infection or MIS-C, particularly in those with comorbidities predisposing to thrombotic events.

Beyond the d-dimer – Machine-learning assisted pre-test probability evaluation in patients with suspected pulmonary embolism and elevated d-dimers

¹

,

²

,

³

et al. 2021

Thrombosis Research

View full text Add to dashboard Cite

No abstract

PO-41 Paraneoplastic deep vein thrombosis in pre-existing full-dose anticoagulation with dabigatran: a case report

Gressenberger³

et al. 2021

Thrombosis Research

View full text Add to dashboard Cite

Coagulation and inflammatory parameters are mildly altered in children with SARS-CoV-2 (COVID-19) infection, and laboratory evidence of a proinflammatory and procoagulant state has been noted in multisystem inflammatory syndrome in children (MIS-C). It is not clear whether this pediatric condition is related to thrombotic events. With this study we reviewed the literature for thrombotic complications in children with COVID-19 infection and MIS-C. Data sources: We searched the Medline PubMed Advanced Search Builder, Scopus, Web Of Science, and Google Scholar electronic databases (until 1 January 2021) using the medical subject headings (MeSH) terms and text words (their combinations and truncated synonyms): (THROMBOSIS OR THROMBOPHILIA) AND (CHILD OR CHILDREN OR INFANT) AND (COVID-19 OR SARS-CoV-2). Study eligibility criteria: Inclusion criteria were children with COVID-19 or SARS-COV-2 infection. The search was limited to articles published in English. Exclusion criteria were: reviews of published studies, studies published only as abstracts, letters or conference proceedings, discussion papers, animal studies, or editorials. Results: After screening for duplicates, the initial search yielded 86 records: 12 were case reports involving 19 children; comorbidities were absent or mild in 73.7%. The most common site of thrombosis the lung (21%); the most often used drug was heparin (42%). Two studies were an international survey (n = 337 patients) and a large multicenter study (n = 186 patients with MIS-C). The risk of ischemic stroke in SARS-CoV-2 infection (0.82%) and deep venous thrombosis in MIS-C (4.3%) was lower in children than in adults. Conclusions: Thrombodic or thromboembolic events are rare in pediatric patients with COVID-19 infection and MIS-C. Nonetheless, as in adults, a high index of suspicion should be maintained in children with COVID-19 infection or MIS-C, particularly in those with comorbidities predisposing to thrombotic events.

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.